MarketCap
Facebook
X
TelegramGeschäftsbericht 2025
hinzugefügt 04.04.2026
Ascendis Pharma A/S DSO 2011-2026 | ASND
DSO Jährlich Ascendis Pharma A/S
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | 132 | 98.3 | 62 | - | - | - |
Alle Zahlen in EUR-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 132 | 62 | 97.5 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.63 | -2.42 % | $ 8.73 B |  Australia |
 |
I-Mab
IMAB
|
271 | - | - | $ 866 M |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B |  USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Precision BioSciences
DTIL
|
6.07 | $ 6.73 | 0.9 % | $ 25.9 M | USA |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Esperion Therapeutics
ESPR
|
99.7 | $ 2.15 | -0.69 % | $ 447 M | USA |
 |
Evogene Ltd.
EVGN
|
30 | $ 0.81 | -0.33 % | $ 27.9 M |  Israel |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 | $ 20.29 | -0.39 % | $ 948 M | USA |
 |
Genmab A/S
GMAB
|
97.9 | $ 28.24 | -0.04 % | $ 18 B |  Danmark |
 |
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | USA |
 |
Adverum Biotechnologies
ADVM
|
222 | - | - | $ 86.2 M | USA |
 |
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | USA |
 |
Halozyme Therapeutics
HALO
|
93.4 | $ 67.79 | -0.05 % | $ 8.12 B | USA |
 |
Aeterna Zentaris
AEZS
|
146 | - | 5.93 % | $ 314 M |  Canada |
 |
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
Akebia Therapeutics
AKBA
|
62.9 | $ 1.42 | 1.07 % | $ 365 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 | - | - | $ 26.5 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 2.96 | 1.37 % | $ 4.87 M | Israel |
 |
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | USA |
 |
Aquestive Therapeutics
AQST
|
103 | $ 4.15 | 1.72 % | $ 444 M | USA |
 |
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 | $ 24.3 | 0.37 % | $ 3.09 B | USA |
 |
Harmony Biosciences Holdings
HRMY
|
37.8 | $ 28.82 | -0.24 % | $ 1.66 B | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Celldex Therapeutics
CLDX
|
321 | $ 32.37 | 0.4 % | $ 2.15 B | USA |
 |
Autolus Therapeutics plc
AUTL
|
58.2 | $ 1.52 | 1.68 % | $ 405 M | Britain |
 |
Cidara Therapeutics
CDTX
|
2.26 K | - | - | $ 1.41 B | USA |
 |
ImmuCell Corporation
ICCC
|
47.5 | $ 7.24 | 2.33 % | $ 65.3 M | USA |
 |
Incyte Corporation
INCY
|
66.6 | $ 96.66 | 0.61 % | $ 18.9 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
150 | $ 2.58 | 1.18 % | $ 16.2 M | USA |